$ELAN
Elanco Animal Health Inc

2019 Q4 Form 10-Q Financial Statement

#000173910419000016 Filed on November 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $787.0M $771.3M $761.1M
YoY Change -1.54% 1.34% 9.18%
Cost Of Revenue $410.1M $360.4M $369.8M
YoY Change -0.58% -2.54% -1.7%
Gross Profit $376.9M $410.9M $391.3M
YoY Change -2.56% 5.01% 21.94%
Gross Profit Margin 47.89% 53.27% 51.41%
Selling, General & Admin $185.9M $192.3M $179.0M
YoY Change 0.43% 7.43% -8.06%
% of Gross Profit 49.32% 46.8% 45.74%
Research & Development $67.30M $69.90M $58.90M
YoY Change 10.15% 18.68% -4.85%
% of Gross Profit 17.86% 17.01% 15.05%
Depreciation & Amortization $83.40M $78.70M $72.70M
YoY Change 13.16% 8.25% -3.32%
% of Gross Profit 22.13% 19.15% 18.58%
Operating Expenses $253.2M $262.2M $237.9M
YoY Change 2.84% 10.21% -7.29%
Operating Profit $123.7M $148.7M $153.4M
YoY Change -12.02% -3.06% 138.57%
Interest Expense $18.70M $18.70M $8.600M
YoY Change -10.95% 117.44%
% of Operating Profit 15.12% 12.58% 5.61%
Other Income/Expense, Net -$6.300M -$14.60M -$4.900M
YoY Change -75.49% 197.96% -357.89%
Pretax Income -$4.300M -$12.50M $78.80M
YoY Change 95.45% -115.86% -965.93%
Income Tax $5.200M -$22.50M $18.60M
% Of Pretax Income 23.6%
Net Earnings -$9.500M $10.00M $60.20M
YoY Change -157.93% -83.39% -390.82%
Net Earnings / Revenue -1.21% 1.3% 7.91%
Basic Earnings Per Share $0.03 $0.20
Diluted Earnings Per Share -$25.48K $0.03 $0.20
COMMON SHARES
Basic Shares Outstanding 373.0M shares 371.6M shares 301.2M shares
Diluted Shares Outstanding 373.2M shares 301.2M shares

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $334.0M $309.0M $300.0M
YoY Change -29.68% 3.0%
Cash & Equivalents $334.0M $309.2M $300.0M
Short-Term Investments
Other Short-Term Assets $98.00M $109.0M $758.0M
YoY Change -69.09% -85.62%
Inventory $1.051B $1.069B $1.009B
Prepaid Expenses
Receivables $816.9M $758.3M $606.1M
Other Receivables $73.00M $65.10M $30.80M
Total Short-Term Assets $2.373B $2.310B $2.704B
YoY Change -5.26% -14.55%
LONG-TERM ASSETS
Property, Plant & Equipment $955.3M $911.7M $909.3M
YoY Change 3.57% 0.26%
Goodwill $2.990B $2.946B $2.969B
YoY Change -0.35% -0.75%
Intangibles $2.483B $2.435B $2.515B
YoY Change -0.88% -3.17%
Long-Term Investments $18.80M $17.90M $15.00M
YoY Change 22.88% 19.33%
Other Assets $185.0M $220.2M $100.0M
YoY Change 177.78% 120.2%
Total Long-Term Assets $6.613B $6.513B $6.508B
YoY Change 2.49% 0.08%
TOTAL ASSETS
Total Short-Term Assets $2.373B $2.310B $2.704B
Total Long-Term Assets $6.613B $6.513B $6.508B
Total Assets $8.986B $8.824B $9.212B
YoY Change 0.32% -4.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $222.6M $206.1M $202.7M
YoY Change 8.48% 1.68%
Accrued Expenses $123.0M $113.0M $81.00M
YoY Change 24.24% 39.51%
Deferred Revenue $211.0M $182.2M $147.9M
YoY Change 24.19% 23.19%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $24.50M $24.50M $0.00
YoY Change -15.52%
Total Short-Term Liabilities $818.5M $741.5M $1.245B
YoY Change -15.68% -40.46%
LONG-TERM LIABILITIES
Long-Term Debt $2.331B $2.336B $2.479B
YoY Change -4.62% -5.77%
Other Long-Term Liabilities $106.6M $96.40M $89.50M
YoY Change -12.26% 7.71%
Total Long-Term Liabilities $2.437B $2.432B $2.568B
YoY Change -4.98% -5.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $818.5M $741.5M $1.245B
Total Long-Term Liabilities $2.437B $2.432B $2.568B
Total Liabilities $3.439B $3.336B $4.074B
YoY Change -8.52% -18.12%
SHAREHOLDERS EQUITY
Retained Earnings $84.30M $93.80M
YoY Change 414.02%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.547B $5.488B $5.137B
YoY Change
Total Liabilities & Shareholders Equity $8.986B $8.824B $9.212B
YoY Change 0.32% -4.21%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$9.500M $10.00M $60.20M
YoY Change -157.93% -83.39% -390.82%
Depreciation, Depletion And Amortization $83.40M $78.70M $72.70M
YoY Change 13.16% 8.25% -3.32%
Cash From Operating Activities $126.3M $39.60M $163.9M
YoY Change -9.46% -75.84% 114.25%
INVESTING ACTIVITIES
Capital Expenditures -$111.4M -$34.20M -$17.80M
YoY Change 85.05% 92.13% -17.97%
Acquisitions
YoY Change
Other Investing Activities $37.10M -$48.80M -$3.600M
YoY Change 206.61% 1255.56% 0.0%
Cash From Investing Activities -$74.30M -$83.00M -$21.40M
YoY Change 54.47% 287.85% -15.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.200M -48.80M 450.9M
YoY Change -98.29% -110.82% 1326.9%
NET CHANGE
Cash From Operating Activities 126.3M 39.60M 163.9M
Cash From Investing Activities -74.30M -83.00M -21.40M
Cash From Financing Activities -6.200M -48.80M 450.9M
Net Change In Cash 45.80M -92.20M 593.4M
YoY Change -116.9% -115.54% 616.67%
FREE CASH FLOW
Cash From Operating Activities $126.3M $39.60M $163.9M
Capital Expenditures -$111.4M -$34.20M -$17.80M
Free Cash Flow $237.7M $73.80M $181.7M
YoY Change 19.03% -59.38% 85.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
Elanco Animal Health Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001739104
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
373004001 shares
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
771300000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
761100000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2284000000.0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2267500000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
360400000 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
369800000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1060200000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1161300000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
69900000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
58900000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
202800000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
185500000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
192300000 USD
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
179000000.0 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
574300000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
550100000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50700000 USD
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
48700000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
149000000.0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
147300000 USD
CY2019Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
77200000 USD
CY2018Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
12400000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
133900000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
82800000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
18700000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
8600000 USD
us-gaap Interest Expense
InterestExpense
60200000 USD
us-gaap Interest Expense
InterestExpense
8600000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14600000 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4900000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-21100000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15600000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
783800000 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
682300000 USD
us-gaap Costs And Expenses
CostsAndExpenses
2201500000 USD
us-gaap Costs And Expenses
CostsAndExpenses
2151200000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12500000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
78800000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
82500000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
116300000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-22500000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46200000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
10000000.0 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
60200000 USD
us-gaap Net Income Loss
NetIncomeLoss
77400000 USD
us-gaap Net Income Loss
NetIncomeLoss
70100000 USD
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
371600000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301200000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
367700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
296000000.0 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
373200000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
301200000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
368700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
296000000.0 shares
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
10000000.0 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
60200000 USD
us-gaap Net Income Loss
NetIncomeLoss
77400000 USD
us-gaap Net Income Loss
NetIncomeLoss
70100000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-58900000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
85100000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-53700000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-21200000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-9400000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20600000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-23400000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-10800000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37700000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
94500000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-30300000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-9800000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27700000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
154700000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
47100000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
60300000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309200000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
474800000 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6300000 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8400000 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
758300000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
651800000 USD
CY2019Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
65100000 USD
CY2018Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
57600000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
1068700000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
1004100000 USD
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
98000000.0 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
113900000 USD
CY2019Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
11100000 USD
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
202700000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
2310400000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
2504900000 USD
CY2019Q3 us-gaap Goodwill
Goodwill
2946400000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
2958000000.0 USD
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2435000000.0 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
118400000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2453000000.0 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
220200000 USD
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
909300000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
878600000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
911700000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
922400000 USD
CY2019Q3 us-gaap Assets
Assets
8823700000 USD
CY2018Q4 us-gaap Assets
Assets
8956700000 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
206100000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
205200000 USD
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
88800000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
98900000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
182200000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
169900000 USD
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
24500000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
29000000.0 USD
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
181500000 USD
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
199000000.0 USD
CY2019Q3 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
58400000 USD
CY2018Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
268700000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
741500000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
970700000 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2335600000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2443300000 USD
CY2019Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
81400000 USD
CY2018Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
109100000 USD
CY2019Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
81100000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
114600000 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
96400000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
121500000 USD
CY2019Q3 us-gaap Liabilities
Liabilities
3336000000.0 USD
CY2018Q4 us-gaap Liabilities
Liabilities
3759200000 USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
372999206 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
372999206 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
365643911 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
365643911 shares
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5646400000 USD
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5403300000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
93800000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16400000 USD
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-252500000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-222200000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
5487700000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
5197500000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8823700000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8956700000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
5197500000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
31500000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-28200000 USD
CY2019Q1 elan Stockholders Equity Separation Adjustments
StockholdersEquitySeparationAdjustments
-7000000.0 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2400000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
5196200000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
35900000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
35600000 USD
CY2019Q2 elan Stockholders Equity Separation Adjustments
StockholdersEquitySeparationAdjustments
-18400000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14300000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
5265500000 USD
CY2019Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1900000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
10000000.0 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37700000 USD
CY2019Q3 elan Stockholders Equity Separation Adjustments
StockholdersEquitySeparationAdjustments
-3000000.0 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11300000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
5487700000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
7780300000 USD
CY2018Q1 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-300000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
72700000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
118600000 USD
CY2018Q1 elan Stockholders Equity Transfers To From Parent
StockholdersEquityTransfersToFromParent
-69200000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
7902100000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-62800000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-222900000 USD
CY2018Q2 elan Stockholders Equity Transfers To From Parent
StockholdersEquityTransfersToFromParent
-40300000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
7576100000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
60200000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
94500000 USD
CY2018Q3 elan Stockholders Equity Transfers To From Parent
StockholdersEquityTransfersToFromParent
-116800000 USD
CY2018Q3 elan Stockholders Equity Separation Adjustments
StockholdersEquitySeparationAdjustments
58300000 USD
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1659700000 USD
CY2018Q3 elan Stockholders Equity Consideration To Parent In Separation
StockholdersEquityConsiderationToParentInSeparation
-4194900000 USD
CY2018Q3 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
5137100000 USD
us-gaap Net Income Loss
NetIncomeLoss
77400000 USD
us-gaap Net Income Loss
NetIncomeLoss
70100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
231100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
222300000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14900000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
12600000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
36700000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
20200000 USD
elan Asset Impairment Charges Including Inventory Write Down
AssetImpairmentChargesIncludingInventoryWriteDown
24700000 USD
elan Asset Impairment Charges Including Inventory Write Down
AssetImpairmentChargesIncludingInventoryWriteDown
102500000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
267000000.0 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
83400000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-20000000.0 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
3500000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
97800000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
347800000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
86000000.0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74300000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
32800000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
41700000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4600000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-160500000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-78900000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
115000000.0 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
2477700000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1659700000 USD
elan Payments Of Separation Related Costs Financing Activities
PaymentsOfSeparationRelatedCostsFinancingActivities
191600000 USD
elan Payments Of Separation Related Costs Financing Activities
PaymentsOfSeparationRelatedCostsFinancingActivities
3559100000 USD
elan Proceeds From Payments To Transactions With Parent
ProceedsFromPaymentsToTransactionsWithParent
6300000 USD
elan Proceeds From Payments To Transactions With Parent
ProceedsFromPaymentsToTransactionsWithParent
-247400000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1700000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3700000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-298600000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
327200000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4100000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15400000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-357200000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
611500000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
677500000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
323400000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
320300000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
934900000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309200000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300000000.0 USD
CY2019Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
11100000 USD
CY2018Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
634900000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
320300000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
934900000 USD
CY2019Q3 elan Number Of Brands In Entitys Portfolio
NumberOfBrandsInEntitysPortfolio
125 brand
CY2019Q3 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
90 country
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:700;line-height:120%;">Note 2. Basis of Presentation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman';font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-indent:9pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">We have prepared the accompanying unaudited condensed consolidated and combined financial statements in accordance with the requirements of Form 10-Q and, therefore, they do not include all information and footnotes necessary for a fair presentation of financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States (GAAP). In our opinion, the financial statements reflect all adjustments (including those that are normal and recurring) that are necessary for a fair presentation of the results of operations for the periods shown. In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates.</span></div><div style="text-indent:9pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">Certain reclassifications have been made to prior periods in the unaudited condensed consolidated and combined financial statements and accompanying notes to conform with the current presentation.</span></div><div style="text-indent:9pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">The information included in this Quarterly Report on Form 10-Q should be read in conjunction with our consolidated and combined financial statements and accompanying notes for the year ended December 31, 2018 included in our Annual Report on Form 10-K filed with the SEC on February 20, 2019.</span></div><div style="text-indent:9pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">For the periods after Separation, the financial statements are prepared on a consolidated basis and reflect the results of operations, comprehensive income, financial position, equity and cash flows resulting from our operations as an independent company. For periods prior to the Separation, our financial statements are combined, have been prepared on a standalone basis, and are derived from Lilly's consolidated financial statements and accounting records. The consolidated and combined financial statements reflect the financial position, results of operations and cash flows related to the animal health businesses that were transferred to Elanco Parent and are prepared in conformity with GAAP.</span></div><div style="text-indent:9pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">The combined financial statements include the attribution of certain assets and liabilities that historically have been held at the Lilly corporate level but which are specifically identifiable or attributable to the businesses that have been transferred to Elanco Parent. All intercompany transactions and accounts within Elanco have been eliminated. All transactions between us and Lilly are considered to be effectively settled in the combined financial statements at </span></div><div style="text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">the time the intercompany transaction is recorded. The total net effect of the settlement of these intercompany transactions is reflected in the combined statements of cash flows as a financing activity and in the condensed consolidated and combined statement of equity as net parent company investment.</span></div><div style="text-indent:9pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">Prior to Separation, these combined financial statements include an allocation of expenses related to certain Lilly corporate functions, including executive oversight, treasury, legal, finance, human resources, tax, internal audit, financial reporting, information technology and investor relations, prior to IPO. These expenses have been allocated to us based on direct usage or benefit where specifically identifiable, with the remainder allocated primarily on a pro rata basis of revenue, headcount and other measures. We consider the expenses methodology and results to be reasonable for all periods presented. However, the allocations may not be indicative of the actual expense that would have been incurred had we operated as an independent, publicly traded company for the periods presented. It is impractical to estimate what the standalone costs of Elanco would have been in the historical periods. After the Separation, a Transitional Services Agreement (TSA) between Lilly and Elanco went into effect. Under the terms of the TSA, we will be able to use these Lilly services for a fixed term established on a service-by-service basis. We are paying Lilly mutually agreed upon fees for the Lilly services provided under the TSA. Our consolidated and combined financial statements reflect the charges for Lilly services after the IPO. See Note 17: Related Party Agreements and Transactions for additional details.</span></div><div style="text-indent:9pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">The income tax amounts in the combined financial statements have been calculated based on a separate return methodology and presented as if our operations were separate taxpayers in the respective jurisdictions. We file income tax returns in the U.S. federal jurisdiction and various state, local and non-U.S. jurisdictions. Prior to full separation, certain of these income tax returns were filed on a consolidated or combined basis with Eli Lilly and Company and/or its subsidiaries.</span></div><div style="text-indent:9pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">Prior to Separation, Lilly maintained various benefit and combined stock-based compensation plans at a corporate level and other benefit plans at a country level. Our employees participated in such programs and the portion of the cost of those plans related to our employees is included in our financial statements. However, the condensed balance sheets do not include any equity issued related to stock-based compensation plans or any net benefit plan obligations unless the benefit plan covers only our dedicated employees or where the legal obligation associated with the benefit plan transferred to Elanco. Upon Lilly's full divestiture of Elanco in March 2019, all Lilly share-based awards held by our employees were converted into awards that will be settled in Elanco shares.</span></div><div style="text-indent:9pt;text-align:justify;margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial';font-size:10pt;font-weight:400;line-height:120%;">Prior to Separation, the equity balance in the combined financial statements represents the excess of total assets over liabilities, including intercompany balances between Elanco and Lilly (net parent company investment) and accumulated other comprehensive income/(loss). Net parent company investment is primarily impacted by contributions from Lilly which are the result of treasury activities and net funding provided by or distributed to Lilly. See Note 17: Related Party Agreements and Transactions for further information.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain reclassifications have been made to prior periods in the unaudited condensed consolidated and combined financial statements and accompanying notes to conform with the current presentation.
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
Payment terms differ by jurisdiction and customer, but payment terms in most of our major jurisdictions typically range from 30 to 120 days from date of shipment.
elan Contract With Customer Rebate Period
ContractWithCustomerRebatePeriod
P6M
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
132100000 USD
CY2018Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
99100000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
118500000 USD
CY2017Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
114800000 USD
CY2019Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
75900000 USD
CY2018Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
53500000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
222200000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
154200000 USD
CY2019Q3 elan Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
78900000 USD
CY2018Q3 elan Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
49100000 USD
elan Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
211600000 USD
elan Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
165500000 USD
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
129100000 USD
CY2018Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
103500000 USD
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
129100000 USD
CY2018Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
103500000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
771300000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
761100000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2284000000.0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2267500000 USD
CY2019Q3 us-gaap Severance Costs1
SeveranceCosts1
10400000 USD
CY2018Q3 us-gaap Severance Costs1
SeveranceCosts1
-200000 USD
us-gaap Severance Costs1
SeveranceCosts1
9600000 USD
us-gaap Severance Costs1
SeveranceCosts1
-2800000 USD
CY2019Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
46100000 USD
CY2018Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
4900000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
99600000 USD
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
10500000 USD
CY2019Q3 us-gaap Business Exit Costs1
BusinessExitCosts1
0 USD
CY2018Q3 us-gaap Business Exit Costs1
BusinessExitCosts1
1500000 USD
us-gaap Business Exit Costs1
BusinessExitCosts1
0 USD
us-gaap Business Exit Costs1
BusinessExitCosts1
11200000 USD
CY2019Q3 elan Restructuring Settlement And Impairment Provisions Excluding Noncash
RestructuringSettlementAndImpairmentProvisionsExcludingNoncash
56500000 USD
CY2018Q3 elan Restructuring Settlement And Impairment Provisions Excluding Noncash
RestructuringSettlementAndImpairmentProvisionsExcludingNoncash
6200000 USD
elan Restructuring Settlement And Impairment Provisions Excluding Noncash
RestructuringSettlementAndImpairmentProvisionsExcludingNoncash
109200000 USD
elan Restructuring Settlement And Impairment Provisions Excluding Noncash
RestructuringSettlementAndImpairmentProvisionsExcludingNoncash
18900000 USD
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
10200000 USD
CY2018Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
6200000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
14200000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
63900000 USD
CY2019Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
10500000 USD
CY2018Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
10500000 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
CY2019Q3 elan Restructuring Settlement And Impairment Provisions Noncash
RestructuringSettlementAndImpairmentProvisionsNoncash
20700000 USD
CY2018Q3 elan Restructuring Settlement And Impairment Provisions Noncash
RestructuringSettlementAndImpairmentProvisionsNoncash
6200000 USD
elan Restructuring Settlement And Impairment Provisions Noncash
RestructuringSettlementAndImpairmentProvisionsNoncash
24700000 USD
elan Restructuring Settlement And Impairment Provisions Noncash
RestructuringSettlementAndImpairmentProvisionsNoncash
63900000 USD
CY2019Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
77200000 USD
CY2018Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
12400000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
133900000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
82800000 USD
CY2017Q4 us-gaap Restructuring Reserve
RestructuringReserve
78000000.0 USD
us-gaap Restructuring Charges
RestructuringCharges
8400000 USD
elan Restructuring Reserve Separation Adjustment
RestructuringReserveSeparationAdjustment
-5900000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
33500000 USD
CY2018Q3 us-gaap Restructuring Reserve
RestructuringReserve
47000000.0 USD
CY2018Q4 us-gaap Restructuring Reserve
RestructuringReserve
44400000 USD
us-gaap Restructuring Charges
RestructuringCharges
40700000 USD
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-10200000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
20800000 USD
CY2019Q3 us-gaap Restructuring Reserve
RestructuringReserve
54100000 USD
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
435100000 USD
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
400700000 USD
CY2019Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
588100000 USD
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
570400000 USD
CY2019Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
84600000 USD
CY2018Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
80400000 USD
CY2019Q3 us-gaap Inventory Gross
InventoryGross
1107800000 USD
CY2018Q4 us-gaap Inventory Gross
InventoryGross
1051500000 USD
CY2019Q3 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
39100000 USD
CY2018Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
47400000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
1068700000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
1004100000 USD
CY2019Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
17700000 USD
CY2018Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
20700000 USD
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
2360100000 USD
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
2472300000 USD
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
24500000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
29000000.0 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2335600000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2443300000 USD
CY2019Q3 us-gaap Equity Method Investments
EquityMethodInvestments
17900000 USD
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
15300000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
6700000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
19000000.0 USD
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
500000 USD
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
500000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
1600000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
7300000 USD
us-gaap Lease Cost
LeaseCost
21100000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
17900000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2000000.0 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
81700000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
24100000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
57600000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
25300000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
20100000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
11500000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
9000000.0 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
7000000.0 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
14900000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
87800000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6100000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
81700000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-22500000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46200000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.797
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.236
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.062
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.397
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-22500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5100000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
46200000 USD
CY2018Q4 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2019Q3 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
771300000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
761100000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2284000000.0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2267500000 USD
CY2019Q3 us-gaap Noncurrent Assets
NoncurrentAssets
1027600000 USD
CY2019Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
11100000 USD
CY2018Q4 us-gaap Noncurrent Assets
NoncurrentAssets
985900000 USD
CY2019Q3 us-gaap Defined Benefit Plan Plan Amendments
DefinedBenefitPlanPlanAmendments
-21000000 USD
CY2019Q3 elan Defined Benefit Plan Benefit Obligation Increase Decrease For Plan Amendment Prior Service Costs
DefinedBenefitPlanBenefitObligationIncreaseDecreaseForPlanAmendmentPriorServiceCosts
-75000000 USD
CY2019Q3 elan Defined Benefit Plan Benefit Obligation Increase Decrease For Plan Amendment Changes In Certain Assumptions
DefinedBenefitPlanBenefitObligationIncreaseDecreaseForPlanAmendmentChangesInCertainAssumptions
-54000000 USD
CY2019Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-21000000 USD
CY2018Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2932900
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7300000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7300000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares

Files In Submission

Name View Source Status
0001739104-19-000016-index-headers.html Edgar Link pending
0001739104-19-000016-index.html Edgar Link pending
0001739104-19-000016.txt Edgar Link pending
0001739104-19-000016-xbrl.zip Edgar Link pending
bylawsadoptedaug82019.htm Edgar Link pending
bylawsadoptedaug82019001.jpg Edgar Link pending
bylawsadoptedaug82019002.jpg Edgar Link pending
bylawsadoptedaug82019003.jpg Edgar Link pending
bylawsadoptedaug82019004.jpg Edgar Link pending
bylawsadoptedaug82019005.jpg Edgar Link pending
bylawsadoptedaug82019006.jpg Edgar Link pending
bylawsadoptedaug82019007.jpg Edgar Link pending
bylawsadoptedaug82019008.jpg Edgar Link pending
bylawsadoptedaug82019009.jpg Edgar Link pending
bylawsadoptedaug82019010.jpg Edgar Link pending
bylawsadoptedaug82019011.jpg Edgar Link pending
bylawsadoptedaug82019012.jpg Edgar Link pending
bylawsadoptedaug82019013.jpg Edgar Link pending
bylawsadoptedaug82019014.jpg Edgar Link pending
bylawsadoptedaug82019015.jpg Edgar Link pending
bylawsadoptedaug82019016.jpg Edgar Link pending
bylawsadoptedaug82019017.jpg Edgar Link pending
bylawsadoptedaug82019018.jpg Edgar Link pending
bylawsadoptedaug82019019.jpg Edgar Link pending
bylawsadoptedaug82019020.jpg Edgar Link pending
bylawsadoptedaug82019021.jpg Edgar Link pending
elan-20190930.htm Edgar Link pending
elan-20190930.xsd Edgar Link pending
elan-20190930_cal.xml Edgar Link unprocessable
elan-20190930_def.xml Edgar Link unprocessable
elan-20190930_htm.xml Edgar Link completed
elan-20190930_lab.xml Edgar Link unprocessable
elan-20190930_pre.xml Edgar Link unprocessable
elanco-20190930exhibit.htm Edgar Link pending
elanco-20190930exhibit1.htm Edgar Link pending
elanco-20190930exhibit2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending